Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Session 4 – Molecular Target / Family of Targets – Immune Infiltration and Immune Checkpoints

Testing for the Target / Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation)

Date

18 Nov 2023

Session

Session 4 – Molecular Target / Family of Targets – Immune Infiltration and Immune Checkpoints

Topics

Immunotherapy; Laboratory Diagnostics; Pathology/Molecular Biology; Targeted Therapy

Tumour Site

Presenters

R. F. Salgado, BE

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

18 Nov 2023

Biology of the Target / Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis)

Presenter: K. Litchfield, UK

Session: Session 4 – Molecular Target / Family of Targets – Immune Infiltration and Immune Checkpoints

Resources:

Slides

Webcast

18 Nov 2023

Update on The Clinical Efficacy of Approved Targeted Agents: Formal Indications, Efficacy and Toxicity

Presenter: Author: S. Turajlic, UK; Presenter: K. Litchfield, UK

Session: Session 4 – Molecular Target / Family of Targets – Immune Infiltration and Immune Checkpoints

Resources:

Slides

Webcast

18 Nov 2023

A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board

Presenter: R. F. Salgado, BE

Session: Session 4 – Molecular Target / Family of Targets – Immune Infiltration and Immune Checkpoints

Resources:

Slides

Webcast

18 Nov 2023

Value/Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD)

Presenter: M. Hubank, UK

Session: Session 4 – Molecular Target / Family of Targets – Immune Infiltration and Immune Checkpoints

Resources:

Slides

Webcast